---
schema_version: "secwatch.filing_event.v1"
accession: "0001179929-24-000086"
form_type: "8-K"
ticker: "MOH"
cik: "0001179929"
company_name: "MOLINA HEALTHCARE, INC."
filed_at: "2024-04-24T23:59:59+00:00"
generated_at: "2026-06-03T09:23:44.808944+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Molina Q1 GAAP EPS $5.17, adjusted $5.73; revenue rises to $9.93B; reaffirms FY2024 guidance

## Summary
- Q1 GAAP EPS $5.17 vs $5.52 YoY; adjusted EPS $5.73 vs $5.81.
- Total revenue $9.93B (+22% YoY) driven by premium revenue of $9.50B.
- Medical care ratio 88.5%, up from 87.1% YoY; G&A ratio stable at 7.2%.
- GAAP net income $301M vs $321M; adjusted net income $334M vs $337M.
- Company reaffirms full-year 2024 revenue and earnings guidance.

## SEC filing metadata
- accession: 0001179929-24-000086
- form_type: 8-K
- ticker: MOH
- cik: 0001179929
- company_name: MOLINA HEALTHCARE, INC.
- filed_at: 2024-04-24T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1179929/000117992924000086/0001179929-24-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1179929/000117992924000086/moh-20240424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001179929-24-000086
- JSON: https://secwatch.observer/filing/0001179929-24-000086.json
- Plain text: https://secwatch.observer/filing/0001179929-24-000086.txt

## Key facts
- Earnings Releases
  MOLINA HEALTHCARE, INC. reported first quarter ended March 31, 2024 results: revenue Premium Revenue $9,504; Total Revenue $9,931, net income Net Income $334, EPS Adjusted EPS – Diluted $5.73. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2024
  - Revenue: Premium Revenue $9,504; Total Revenue $9,931
  - Net income: Net Income $334
  - EPS: Adjusted EPS – Diluted $5.73
  - Guidance: reaffirmed
  - Result: reported results
  source text: earnings per diluted share of $5.73. Financial results are summarized below: Three months ended March 31, 2024 2023 (In millions, except per-share results) Premium Revenue $9,504 $7,885 Total Revenue $9,931 $8,149 GAAP: Net Income $301 $321 EPS – Diluted $5.17 $5.52 Medical Care Ratio (MCR) 88.5 % 87.1 % G&A Ratio 7.2 % 7.2 % After-tax Margin 3.0 % 3.9 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1179929/000117992924000086/0001179929-24-000086-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.